GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE Drug Patent Profile
When do Guaifenesin And Dextromethorphan Hydrobromide patents expire, and when can generic versions of Guaifenesin And Dextromethorphan Hydrobromide launch?
Guaifenesin And Dextromethorphan Hydrobromide is a drug marketed by Actavis Labs Fl, Amneal Pharms, Aurobindo Pharma, Dr Reddys, Perrigo R And D, and Sun Pharm. and is included in six NDAs.
The generic ingredient in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE is dextromethorphan hydrobromide; guaifenesin. There is one drug master file entry for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What are the global sales for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
- What is Average Wholesale Price for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE?
Summary for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 59 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 20 |
| What excipients (inactive ingredients) are in GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE? | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE excipients list |
| DailyMed Link: | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE at DailyMed |
Pharmacology for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| Drug Class | Expectorant Sigma-1 Agonist Uncompetitive N-methyl-D-aspartate Receptor Antagonist |
| Mechanism of Action | Sigma-1 Receptor Agonists Uncompetitive NMDA Receptor Antagonists |
| Physiological Effect | Decreased Respiratory Secretion Viscosity Increased Respiratory Secretions |
US Patents and Regulatory Information for GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 091070-001 | Aug 31, 2015 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 217340-001 | Aug 1, 2023 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal Pharms | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | dextromethorphan hydrobromide; guaifenesin | TABLET, EXTENDED RELEASE;ORAL | 209692-002 | Nov 1, 2018 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
